Real-time enrollment status for this hypercholesterolaemia clinical trial
Current Status
Recruiting
Checked: October 5, 2026 at 11:52 PM UTC
| NCT Number | NCT07619118 |
| Recruiting Status | Recruiting |
| Condition | Hypercholesterolaemia |
| Phase | PHASE3 |
| Target Enrollment | 200 participants |
| Active Locations | 26 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | October 5, 2026 (23 hours ago) |
As of October 5, 2026: Clinical trial NCT07619118 is currently recruiting participants. This phase3 study for hypercholesterolaemia is actively seeking new participants at 26 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07619118 is actively recruiting participants as of October 5, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07619118 was last updated 23 hours ago (October 5, 2026). HelloStudys verifies this status automatically.